AI/ML PROGRAMMABLE MOLECULE SIMULATION PLATFORM

Redefining Drug Conjugates with AI-First Design

AracodeX is an AI-first programmable-molecule company focused on redefining how drug conjugates are designed, optimized, and translated into precision therapeutics. We develop an integrated platform that combines AI-driven molecular simulation with modular chemical and biological building blocks, including non-canonical amino acids (ncAAs) and programmable linker scaffolds, to systematically engineer drug conjugates or drug delivery carriers with improved safety, stability, and therapeutic index.

1

Data Foundation

Comprehensive ncAA sequence structure v.s. mechanical features database. Utilize diverse ncAA sequence combinations and leverage the Cell-Free Protein Synthesis (CFPS) system to rapidly generate products for systematic feature testing.

2

AI/ML Predictive model

Robust computational infrastructure of the design-build-test-learn cycle to identify the optimal biomaterial sequences. Implement advanced AI/ML simulation models to analyze sequence data, molecular structures, and mechanical properties.

3

Biomanufacture

Cutting-edge microbial system that leverages ncAA expression to produce innovative, polymerized sequence-defined biomaterials. A remarkable and scalable fermentation device to facilitate efficient large-scale production.